We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Anti-Inflammatory Effect of Omega-3 Fatty Acids Due to Activation of GPR120

By LabMedica International staff writers
Posted on 01 Dec 2010
The molecular basis for the anti-inflammatory action of fish oil (heavily enriched with omega-3 fatty acids) was studied, and the key element was found to be the protein GPR120.

GPR120, a G protein-coupled receptor found primarily in fat tissue and on macrophages, is a member of a class of receptors that is involved in many cell functions and is a frequent drug target. More...


In the current study investigators at the University of California, San Diego (USA) looked at the relationship between omega-3 fatty acids and GPR120. To this end they fed obese wild type mice and mice that had been genetically engineered to lack the gene for GPR120 (GPR120 knockout mice) a high fat diet with or without omega-3 fatty acid supplementation.

They reported in the September 3, 2010, online edition of the journal Cell that the omega-3 fatty acid treatment inhibited inflammation and enhanced systemic insulin sensitivity in the wild type mice, but was without effect in the GPR120 knockout mice. GPR120 acted as a functional omega-3 fatty acid receptor/sensor and mediated potent insulin sensitizing and antidiabetic effects in vivo by repressing macrophage-induced tissue inflammation.

"Omega-3s are very potent activators of GPR120 on macrophages - more potent than any other anti-inflammatory we have ever seen,” said senior author Dr. Jerrold Olefsky, professor of endocrinology and metabolism at the University of California, San Diego.

Related Links:
University of California, San Diego



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.